Your browser doesn't support javascript.
loading
Cutaneous sarcoidosis: clinico-epidemiological profile of 72 patients at a tertiary hospital in São Paulo, Brazil,
Hospital das ClínicasTorquato, Mariana Fernandes; Hospital das ClínicasCosta, Marcella Karen Souza da; Hospital das ClínicasNico, Marcello Menta Simonsen.
  • Hospital das ClínicasTorquato, Mariana Fernandes; Universidade de São Paulo. Faculdade de Medicina. Hospital das ClínicasTorquato, Mariana Fernandes. São Paulo. BR
  • Hospital das ClínicasCosta, Marcella Karen Souza da; Universidade de São Paulo. Faculdade de Medicina. Hospital das ClínicasCosta, Marcella Karen Souza da. São Paulo. BR
  • Hospital das ClínicasNico, Marcello Menta Simonsen; Universidade de São Paulo. Faculdade de Medicina. Hospital das ClínicasNico, Marcello Menta Simonsen. São Paulo. BR
An. bras. dermatol ; 95(1): 57-62, Jan.-Feb. 2020. tab, graf
Article in English | LILACS | ID: biblio-1088735
ABSTRACT
Abstract

Background:

Sarcoidosis is a multisystem disease of unknown cause that is characterized by the presence of granulomas in various organs. Cutaneous involvement is common and the reported incidence has varied from 9% to 37%. Studies on cutaneous sarcoidosis in Brazil are lacking.

Objectives:

To describe the clinical and epidemiological aspects of patients with cutaneous sarcoidosis diagnosed at the Department of Dermatology of the University of São Paulo, from May 1994 to March 2018.

Methods:

Clinical data of patients with confirmed cutaneous sarcoidosis were retrospectively reviewed and classified according to gender, ethnicity, age at diagnosis, cutaneous presentation, systemic involvement and treatment.

Results:

Cutaneous sarcoidosis was diagnosed in 72 patients with a female predominance (74%). The mean age at diagnosis was 49.6 years and most of the patients were white (61%). Papules and plaques were the most common lesions. Systemic sarcoidosis was detected in 81% of patients, affecting mainly the lungs and thoracic lymph nodes (97%). Typically, cutaneous lesions were the first manifestation (74%). Systemic therapy was necessary for 72% of patients; the dermatologist managed many of these cases. Oral glucocorticoids were the most commonly used systemic medication (92%). The mean number of systemic drugs used was 1.98 per patient.

Limitations:

Insufficient data in medical records.

Conclusions:

This series highlights the dermatologist role in recognizing and diagnosing cutaneous sarcoidosis, evaluating patients for systemic disease involvement and treating the skin manifestations. Cutaneous sarcoidosis was once considered exceedingly infrequent in Brazil in comparison to infectious granulomatous diseases; however, the present series seems to suggest that the disease is not so rare in this region.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Sarcoidosis / Skin Diseases / Tertiary Care Centers Type of study: Incidence study / Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Sarcoidosis / Skin Diseases / Tertiary Care Centers Type of study: Incidence study / Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR